DexCom Stock Options Expiring on 15th of August
| DXCM Stock | USD 83.89 0.21 0.25% |
DexCom's latest option contracts expiring on August 15th 2025 are carrying combined implied volatility of 0.67 with a put-to-call open interest ratio of 4.22 over 29 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on August 15th 2025. The total put volume is at 280, with calls trading at the volume of 153. This yields a 1.83 put-to-call volume ratio.
Open Interest Against August 15th 2025 Option Contracts
2025-08-15
The chart above shows DexCom's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. DexCom's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for DexCom's option, there is no secondary market available for investors to trade.
DexCom Maximum Pain Price Across 2025-08-15 Option Contracts
Max pain occurs when DexCom's market makers reach a net positive position across all DexCom's options at a strike price where option holders stand to lose the most money. By contrast, DexCom's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Please note that buying 'in-the-money' options on DexCom lessens the impact of time decay, as they carry both intrinsic and time value. So, even if DexCom's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money DexCom contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if DexCom Stock moves the wrong way.
DexCom Inc In The Money Call Balance
When DexCom's strike price is surpassing the current stock price, the option contract against DexCom Inc stock is said to be in the money. When it comes to buying DexCom's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on DexCom Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
DexCom Current Options Market Mood
DexCom's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps DexCom Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most DexCom's options investors are not very successful. DexCom's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current DexCom contract
Base on the Rule 16, the options market is currently suggesting that DexCom Inc will have an average daily up or down price movement of about 0.0419% per day over the life of the 2025-08-15 option contract. With DexCom trading at USD 83.89, that is roughly USD 0.0351. If you think that the market is fully incorporating DexCom's daily price movement you should consider buying DexCom Inc options at the current volatility level of 0.67%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
DexCom Option Chain
When DexCom's strike price is surpassing the current stock price, the option contract against DexCom Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
DexCom's option chain is a display of a range of information that helps investors for ways to trade options on DexCom. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for DexCom. It also shows strike prices and maturity days for a DexCom against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | DXCM250815C00130000 | 0 | 130.0 | 0.0 - 0.25 | 0.25 | |
Call | DXCM250815C00125000 | 0 | 125.0 | 0.0 - 2.15 | 2.15 | |
Call | DXCM250815C00120000 | 0 | 120.0 | 0.0 - 2.2 | 2.2 | |
Call | DXCM250815C00115000 | 0 | 115.0 | 0.0 - 1.0 | 1.0 | |
Call | DXCM250815C00110000 | 31 | 110.0 | 0.0 - 0.35 | 0.35 | Out |
Call | DXCM250815C00105000 | 115 | 105.0 | 0.0 - 0.6 | 0.4 | Out |
Call | DXCM250815C00100000 | 343 | 100.0 | 0.65 - 0.9 | 0.73 | Out |
Call | DXCM250815C00095000 | 626 | 95.0 | 1.3 - 1.5 | 1.35 | Out |
Call | DXCM250815C00090000 | 1123 | 90.0 | 2.5 - 2.8 | 2.54 | Out |
Call | DXCM250815C00085000 | 344 | 85.0 | 4.4 - 4.7 | 4.5 | Out |
Call | DXCM250815C00080000 | 337 | 80.0 | 7.1 - 7.5 | 7.0 | In |
Call | DXCM250815C00075000 | 149 | 75.0 | 10.4 - 11.7 | 12.25 | In |
Call | DXCM250815C00070000 | 6 | 70.0 | 14.6 - 15.4 | 15.3 | In |
Call | DXCM250815C00065000 | 2 | 65.0 | 19.1 - 19.9 | 20.39 | In |
Put | DXCM250815P00130000 | 0 | 130.0 | 44.5 - 46.6 | 44.5 | In |
Put | DXCM250815P00125000 | 0 | 125.0 | 39.5 - 42.1 | 39.5 | In |
Put | DXCM250815P00120000 | 0 | 120.0 | 34.4 - 36.8 | 34.4 | In |
Put | DXCM250815P00115000 | 0 | 115.0 | 29.7 - 32.7 | 29.7 | In |
Put | DXCM250815P00110000 | 0 | 110.0 | 25.9 - 26.7 | 25.9 | In |
Put | DXCM250815P00105000 | 0 | 105.0 | 21.0 - 21.8 | 21.0 | In |
Put | DXCM250815P00100000 | 0 | 100.0 | 16.3 - 17.0 | 16.3 | In |
Put | DXCM250815P00095000 | 133 | 95.0 | 12.0 - 12.7 | 12.0 | In |
Put | DXCM250815P00090000 | 170 | 90.0 | 8.2 - 8.8 | 8.5 | In |
Put | DXCM250815P00085000 | 684 | 85.0 | 5.3 - 5.5 | 5.5 | In |
Put | DXCM250815P00080000 | 2758 | 80.0 | 3.0 - 3.2 | 3.2 | Out |
Put | DXCM250815P00075000 | 2000 | 75.0 | 1.5 - 1.65 | 1.55 | Out |
Put | DXCM250815P00070000 | 2530 | 70.0 | 0.7 - 0.95 | 0.78 | Out |
Put | DXCM250815P00065000 | 4692 | 65.0 | 0.25 - 0.55 | 0.45 | Out |
Put | DXCM250815P00045000 | 1 | 45.0 | 0.0 - 0.2 | 0.15 | Out |
DexCom Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
DexCom Total Stockholder Equity
Total Stockholder Equity |
|
DexCom Corporate Management
| Shelly Selvaraj | Senior Officer | Profile | |
| Leverne Marsh | Executive Marketing | Profile | |
| Matthew Dolan | Executive Development | Profile | |
| Teri Lawver | Executive Officer | Profile | |
| Donald Abbey | Quality Services | Profile | |
| Jereme Sylvain | CFO VP | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.26) | Earnings Share 1.33 | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.